Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Process evaluation of the Prevent Overdose in Toronto (POINT) program.

Leece P, Gassanov M, Hopkins S, Marshall C, Millson P, Shahin R.

Can J Public Health. 2016 Oct 20;107(3):e224-e230. doi: 10.17269/cjph.107.5480.

PMID:
27763835
2.

Beyond viral response: A prospective evaluation of a community-based, multi-disciplinary, peer-driven model of HCV treatment and support.

Mason K, Dodd Z, Sockalingam S, Altenberg J, Meaney C, Millson P, Powis J.

Int J Drug Policy. 2015 Oct;26(10):1007-13. doi: 10.1016/j.drugpo.2015.04.012. Epub 2015 Apr 29.

PMID:
26005037
3.

Hepatitis C virus seroconversion among HIV-positive men who have sex with men with no history of injection drug use: Results from a clinical HIV cohort.

Burchell AN, Gardner SL, Mazzulli T, Manno M, Raboud J, Allen VG, Bayoumi AM, Kaul R, McGee F, Millson P, Remis RS, Wobeser W, Cooper C, Rourke SB.

Can J Infect Dis Med Microbiol. 2015 Jan-Feb;26(1):17-22.

4.

Increasing public support for supervised injection facilities in Ontario, Canada.

Strike C, Jairam JA, Kolla G, Millson P, Shepherd S, Fischer B, Watson TM, Bayoumi AM.

Addiction. 2014 Jun;109(6):946-53. doi: 10.1111/add.12506. Epub 2014 Mar 10.

PMID:
24520984
5.

Non-physician clinician provided HIV treatment results in equivalent outcomes as physician-provided care: a meta-analysis.

Emdin CA, Chong NJ, Millson PE.

J Int AIDS Soc. 2013 Jul 3;16:18445. doi: 10.7448/IAS.16.1.18445. Review.

6.

Patterns of syphilis testing in a large cohort of HIV patients in Ontario, Canada, 2000-2009.

Burchell AN, Allen VG, Moravan V, Gardner S, Raboud J, Tan DH, Bayoumi AM, Kaul R, Mazzulli T, McGee F, Millson P, Remis RS, Rourke SB; OHTN Cohort Study Research Team.

BMC Infect Dis. 2013 May 28;13:246. doi: 10.1186/1471-2334-13-246.

7.
8.

Design considerations for supervised consumption facilities (SCFs): preferences for facilities where people can inject and smoke drugs.

Watson TM, Strike C, Kolla G, Penn R, Jairam J, Hopkins S, Luce J, Degani N, Millson P, Bayoumi AM.

Int J Drug Policy. 2013 Mar;24(2):156-63. doi: 10.1016/j.drugpo.2012.09.003. Epub 2012 Oct 22.

PMID:
23085257
9.

Guidelines for better harm reduction: evaluating implementation of best practice recommendations for needle and syringe programs (NSPs).

Strike C, Watson TM, Lavigne P, Hopkins S, Shore R, Young D, Leonard L, Millson P.

Int J Drug Policy. 2011 Jan;22(1):34-40. doi: 10.1016/j.drugpo.2010.03.007. Epub 2010 Apr 22.

PMID:
20413288
10.

A human immunodeficiency virus risk reduction intervention for incarcerated youth: a randomized controlled trial.

Goldberg E, Millson P, Rivers S, Manning SJ, Leslie K, Read S, Shipley C, Victor JC.

J Adolesc Health. 2009 Feb;44(2):136-145. doi: 10.1016/j.jadohealth.2008.07.021. Epub 2008 Nov 7.

PMID:
19167662
11.

Preventing HIV transmission among Iranian prisoners: initial support for providing education on the benefits of harm reduction practices.

Eshrati B, Asl RT, Dell CA, Afshar P, Millson PM, Kamali M, Weekes J.

Harm Reduct J. 2008 Jun 9;5:21. doi: 10.1186/1477-7517-5-21.

12.

Vaccine immunogenicity in injecting drug users: a systematic review.

Baral S, Sherman SG, Millson P, Beyrer C.

Lancet Infect Dis. 2007 Oct;7(10):667-74. Review.

PMID:
17897609
13.

Reduction in injection-related HIV risk after 6 months in a low-threshold methadone treatment program.

Millson P, Challacombe L, Villeneuve PJ, Strike CJ, Fischer B, Myers T, Shore R, Hopkins S.

AIDS Educ Prev. 2007 Apr;19(2):124-36.

PMID:
17411415
14.

Trends in HIV-1 in young adults in south India from 2000 to 2004: a prevalence study.

Kumar R, Jha P, Arora P, Mony P, Bhatia P, Millson P, Dhingra N, Bhattacharya M, Remis RS, Nagelkerke N; International Studies of HIV/AIDS (ISHA) Investigators.

Lancet. 2006 Apr 8;367(9517):1164-72.

PMID:
16616559
15.

Determinants of health-related quality of life of opiate users at entry to low-threshold methadone programs.

Millson P, Challacombe L, Villeneuve PJ, Strike CJ, Fischer B, Myers T, Shore R, Hopkins S.

Eur Addict Res. 2006;12(2):74-82.

PMID:
16543742
16.

Nonfinancial factors associated with decreased plasma viral load testing in Ontario, Canada.

Raboud JM, Abdurrahman ZB, Major C, Millson P, Robinson G, Rachlis A, Bayoumi AM.

J Acquir Immune Defic Syndr. 2005 Jul 1;39(3):327-32.

PMID:
15980694
17.

Self-perceived health among Canadian opiate users: a comparison to the general population and to other chronic disease populations.

Millson PE, Challacombe L, Villeneuve PJ, Fischer B, Strike CJ, Myers T, Shore R, Hopkins S, Raftis S, Pearson M.

Can J Public Health. 2004 Mar-Apr;95(2):99-103.

PMID:
15074898
18.

Regional variation in HIV prevalence and risk behaviours in Ontario injection drug users (IDU).

Millson P, Myers T, Calzavara L, Wallace E, Major C, Degani N.

Can J Public Health. 2003 Nov-Dec;94(6):431-5.

PMID:
14700242
19.

Consensus statement from the consensus conference on blood-borne human immunodeficiency virus and hepatitis: optimizing the donor-selection process.

King SM, AuBuchon J, Barrowman N, Follea G, Giroux M, Kim W, Kreppner J, Millson P, Squires B, Shaul RZ.

Vox Sang. 2002 Aug;83(2):188-93. Review. No abstract available.

PMID:
12201853
20.

Increases in HIV incidence among men who have sex with men undergoing repeat diagnostic HIV testing in Ontario, Canada.

Calzavara L, Burchell AN, Major C, Remis RS, Corey P, Myers T, Millson P, Wallace E; Polaris Study Team.

AIDS. 2002 Aug 16;16(12):1655-61.

PMID:
12172087
21.

Needle exchange programs: an economic evaluation of a local experience.

Gold M, Gafni A, Nelligan P, Millson P.

CMAJ. 1997 Aug 1;157(3):255-62.

22.

HIV-positive women living in the metropolitan Toronto area: their experiences and perceptions related to HIV testing. The HIV Women's Study Group.

Jackson LA, Millson P, Calzavara L, Rachlis A, Rowe C, Strathdee S, Wagner C, Walmsley S.

Can J Public Health. 1997 Jan-Feb;88(1):18-22.

PMID:
9094799
23.

Prevalence of human immunodeficiency virus and associated risk behaviour in injection drug users in Toronto.

Millson P, Myers T, Rankin J, McLaughlin B, Major C, Mindell W, Coates R, Rigby J, Strathdee S.

Can J Public Health. 1995 May-Jun;86(3):176-80.

PMID:
7671202

Supplemental Content

Loading ...
Support Center